Alabama

Alabama is home to a rapidly expanding life sciences ecosystem, characterized by a unique synergy between academic research, biotechnology and high-capacity pharmaceutical manufacturing.

The state is anchored by the University of Alabama at Birmingham (UAB), a global leader in precision medicine and biomedical research that consistently ranks among the top NIH-funded institutions. Complementing this is the HudsonAlpha Institute for Biotechnology in Huntsville, a premier hub for genomic research and bioscience entrepreneurship where startups and established firms collaborate on multi-omic breakthroughs.

Alabama's pharmaceutical sector is currently witnessing historic growth, highlighted by Eli Lilly's $6 billion investment in a next-generation active pharmaceutical ingredient (API) facility, reinforcing the state's role in onshoring supply chains.

The region's medical device and diagnostics industry also thrives through innovators like Discovery Life Sciences and Avanti Polar Lipids, which provide critical components for global drug discovery.

Southern Research further solidifies Alabama's reputation in translational medicine, having developed seven FDA-approved anti-cancer drugs and continuing to lead in infectious disease research.

Strategically located within Cummings Research Park, the second-largest research park in the US, the ecosystem benefits from a robust talent pipeline and a business-friendly environment for healthcare innovation.

From AI-driven drug development to advanced biomaterials, Alabama is positioning itself as a top-tier destination for life sciences and clinical trial excellence.